-

Nicoya provides complimentary Surface Plasmon Resonance support for researchers during COVID-19

SPR expertise to help researchers accelerate development for coronavirus vaccine

KITCHENER, Ontario--(BUSINESS WIRE)--Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that they will be offering Surface Plasmon Resonance (SPR) technical support to all researchers - at no cost - during COVID-19.

The global impact of COVID-19 has made SARS-CoV-2 vaccine development a priority for researchers around the world. Finding a solution involves understanding the molecular characteristics of the virus through structural data, binding affinity and kinetics. SPR technology allows researchers to obtain this data in real-time and without the use of labels.

To help accelerate COVID-19 research and support the scientific community, Nicoya is offering SPR support for data analysis or experimental design at no cost. With this initiative, Nicoya aims to help researchers obtain high-quality binding kinetics data faster so they can better understand disease pathways, lead generation, and candidate validation. Researchers interested in requesting SPR support can do so at nicoyalife.com/covid-19-spr-support.

"Nicoya has a long history of standing behind scientists,” said Ryan Denomme, co-founder and CEO of Nicoya. “Now that this epidemic has brought their work to the forefront, it’s even more important that we do what we can to empower scientific research."

Nicoya’s mission is to improve human life by helping scientists succeed. With the launch of this new initiative, the company aims to support the scientific community and accelerate COVID-19 research. For a full list of ways Nicoya is supporting researchers in the fight against COVID-19, including their latest research on the binding of a SARS-CoV-2 antibody to the SARS-CoV-2 spike protein receptor binding domain, visit their website.

About Nicoya
Nicoya is a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries. The Canadian company’s mission is to improve human life by helping scientists succeed. Its instruments are used by hundreds of world-renowned researchers in over 40 different countries. Information about Nicoya can be found at nicoyalife.com, on Twitter, Facebook, LinkedIn, and Instagram.

Contacts

Tina Nguyen
Nicoya
1-877-673-6777 ext. 709
tina@nicoyalife.com

Nicoya


Release Summary
SPR expertise to help researchers accelerate development for coronavirus vaccine.
Release Versions

Contacts

Tina Nguyen
Nicoya
1-877-673-6777 ext. 709
tina@nicoyalife.com

Social Media Profiles
More News From Nicoya

Nicoya Launches Alto Automation Suite to Facilitate SPR Integration Into High-Throughput Biologics Discovery Workflows

KITCHENER, Ontario--(BUSINESS WIRE)--Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technologies, announces the launch of the Alto Automation Suite™ for its flagship Alto™ Digital SPR™ system. This makes Alto the world’s first SPR platform that is fully compatible with standard lab automation, enabling thousands of samples per week to be run without human intervention. “With the rapid evolution of AI in protein design, it’s becoming increasingly impor...

Nicoya Expands Into India With Appointment of Medispec as Exclusive Distributor

KITCHENER, Ontario--(BUSINESS WIRE)--Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technology, is pleased to announce the appointment of Medispec as its exclusive distributor in India. This strategic partnership marks a significant milestone in Nicoya's commitment to providing cutting-edge research solutions to the scientific community around the globe. Nicoya is renowned for its state-of-the-art Alto™ and OpenSPR® platforms that are designed to acce...

Nicoya Completes Acquisition of LSK Technologies, Expanding Digital Platform into Molecular Testing

KITCHENER, Ontario--(BUSINESS WIRE)--Nicoya completes acquisition of LSK Technologies to expand its digital proteomics platform into molecular testing....
Back to Newsroom